Literature DB >> 30120137

Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma.

Mehdi Touat1, Julie Gratieux1, Stephanie Condette Auliac1, Karine Sejean1, Sorin Aldea1, Julien Savatovsky1, Géraldine Perkins1, Hélène Blons1, Keith L Ligon1, Ahmed Idbaih1, Antoine Hollebecque1, Anne-Paule Gimenez-Roqueplo1, Pierre Laurent-Puig1, Marc Sanson1, Chiara Villa1, Anna Luisa Di Stefano2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30120137     DOI: 10.1212/WNL.0000000000006171

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?

Authors:  Marco Crocco; Antonio Verrico; Claudia Milanaccio; Gianluca Piccolo; Patrizia De Marco; Gabriele Gaggero; Valentina Iurilli; Sonia Di Profio; Federica Malerba; Marta Panciroli; Paolo Giordano; Maria Grazia Calevo; Emilio Casalini; Natascia Di Iorgi; Maria Luisa Garrè
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

2.  Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.

Authors:  Adam Kowalewski; Justyna Durślewicz; Marek Zdrenka; Dariusz Grzanka; Łukasz Szylberg
Journal:  Target Oncol       Date:  2020-08       Impact factor: 4.493

Review 3.  BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors.

Authors:  Karisa C Schreck; Stuart A Grossman; Christine A Pratilas
Journal:  Cancers (Basel)       Date:  2019-08-28       Impact factor: 6.639

Review 4.  Oncogenic BRAF Alterations and Their Role in Brain Tumors.

Authors:  Felix Behling; Jens Schittenhelm
Journal:  Cancers (Basel)       Date:  2019-06-08       Impact factor: 6.639

5.  Adult pilocytic astrocytoma in the molecular era: a comprehensive review.

Authors:  Timothy A Gregory; Lyndon B Chumbley; John W Henson; Brett J Theeler
Journal:  CNS Oncol       Date:  2021-01-15

Review 6.  Innovating Strategies and Tailored Approaches in Neuro-Oncology.

Authors:  Alberto Picca; David Guyon; Orazio Santo Santonocito; Capucine Baldini; Ahmed Idbaih; Alexandre Carpentier; Antonio Giuseppe Naccarato; Mario Caccese; Giuseppe Lombardi; Anna Luisa Di Stefano
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.